30
Views
1
CrossRef citations to date
0
Altmetric
LetterToEditor

A case of autoimmune polyglandular syndrome type III with a slowly progressive form of type‐1 diabetes mellitus that manifested in the course of autoimmune diseases

, , , , , & show all
Pages 81-82 | Received 08 Feb 2005, Accepted 18 Apr 2005, Published online: 12 Jul 2009

References

  • Shimomura H., Nakase Y., Furuta H., Nishi M., Nakao T., Hanabusa T., et al. A case of autoimmune polyglandular syndrome type 3. Diabetes Res Clin Pract 2003; 61: 103–8
  • Binder A., Maddison P. J., Skinner P., Kurtz A., Isenberg D. A. Sjögren's syndrome association with type‐1 diabetes mellitus. Br J Rheumatol 1989; 28: 518–20
  • Wallaschofski H., Meyer A., Tuschy U., Lohmann T. HLA‐DQA1*0301‐associated susceptibility for autoimmune polyglandular syndrome type II and III. Horm Metab Res 2003; 35: 120–4
  • Matejkova‐Behanova M. Latent autoimmune diabetes in adults (LADA): an autoimmune thyroiditis. Endocr Regul 2001; 35: 167–72
  • Tsiavou A., Degiannis D., Hatziagelaki E., Koniavitou K., Raptis S. A. Intracellular IFN‐gamma production and IL‐12 serum levels in latent autoimmune diabetes of adults (LADA) and in type 2 diabetes. J Interferon Cytokine Res 2004; 24: 381–7
  • Cha S., Nagashima H., Brown V. B., Peck A. B., Humphreys‐Beher M. G. Two NOD Idd‐associated intervals contribute synergistically to the development of autoimmune exocrinopathy (Sjögren's syndrome) on a healthy murine background. Arthritis Rheum 2002; 46: 1390–8
  • Hrda P., Sterzl I., Matucha P., Korioth F., Kromminga A. HLA antigen expression in autoimmune endocrinopathy. Physiol Res 2004; 53: 191–7
  • Roep B. O., Hiemstra H. S., Schloot N. C., De Vries R. R., Chaudhuri A., Behan P. O., et al. Molecular mimicry in type 1 diabetes: immune cross‐reactivity between islet autoantigen and human cytomegalovirus but not Coxsackie virus. Ann N Y Acad Sci 2002; 958: 163–5
  • Kukreja A., Maclaren N. K. Current cases in which epitope mimicry is considered as a component cause of autoimmune disease: immune‐mediated (type 1) diabetes. Cell Mol Life Sci 2000; 57: 534–41

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.